Geneva, Oct. 27 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134563) titled 'Intensive lipid-lowering and plaque regression in symptomatic intracranial atherosclerotic stenosis patients with high-risk lipid subfractions: A prospective single-center real-world study' on Oct. 16.

Study Type: Observational study

Study Design: Cohort study

Primary Sponsor: The First People's Hospital of Foshan

Condition: Symptomatic ICAS patients

Intervention: Intensive Combination Group, IC:N/A

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2027-01-01

Target Sample Size: Intensive Combination Group, IC:100;Standard of Care Group, SoC:100;

Countries of Recruitment: Chi...